The fund is reshaping its structure to focus on four business platforms: UAE investments, disruptive investments, direct investments and real estate and infrastructure
The funds will be invested in the upscaling of biologics strategy, data-driven precision medicine processes, and multimodality drug discovery and development platforms, among others
No portfolio is recession proof and what is required is a well-planned strategy on managing the downside risk, says Vijay Valecha, CIO, Century Financial